Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003515717 | SCV004266775 | uncertain significance | Nemaline myopathy 2 | 2023-11-23 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 856 of the NEB protein (p.Ile856Thr). This variant is present in population databases (rs771567277, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with NEB-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004654247 | SCV005146335 | uncertain significance | Inborn genetic diseases | 2024-06-11 | criteria provided, single submitter | clinical testing | The c.2567T>C (p.I856T) alteration is located in exon 27 (coding exon 25) of the NEB gene. This alteration results from a T to C substitution at nucleotide position 2567, causing the isoleucine (I) at amino acid position 856 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |